Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials. (March 2021)
- Record Type:
- Journal Article
- Title:
- Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials. (March 2021)
- Main Title:
- Remdesivir for the treatment of coronavirus COVID-19: A meta-analysis of randomised controlled trials
- Authors:
- Enoki, Yuki
Igarashi, Yuki
Watabe, Yuki
Honma, Kyoka
Suzuki, Yuto
Hayashi, Yukitaka
Hiraoka, Kana
Taguchi, Kazuaki
Matsumoto, Kazuaki - Abstract:
- Highlights: Remdesivir is proposed as a therapeutic for COVID-19 Clinical improvement after remdesivir was higher compared with placebo Remdesivir tended to reduce patient mortality rate, but this was not significant
- Is Part Of:
- Journal of global antimicrobial resistance. Volume 24(2021)
- Journal:
- Journal of global antimicrobial resistance
- Issue:
- Volume 24(2021)
- Issue Display:
- Volume 24, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 24
- Issue:
- 2021
- Issue Sort Value:
- 2021-0024-2021-0000
- Page Start:
- 81
- Page End:
- 82
- Publication Date:
- 2021-03
- Subjects:
- Drug resistance -- Periodicals
Drug resistance -- Periodicals
Drug resistance
Periodicals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22137165 ↗
http://www.sciencedirect.com/ ↗
http://www.bibliothek.uni-regensburg.de/ezeit/?2710046 ↗
http://www.elsevier.com/locate/jgar ↗ - DOI:
- 10.1016/j.jgar.2020.11.022 ↗
- Languages:
- English
- ISSNs:
- 2213-7165
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17206.xml